{"id":1607,"date":"2015-06-18T10:14:30","date_gmt":"2015-06-18T07:14:30","guid":{"rendered":"http:\/\/www.vilkaviskiovsb.lt\/?p=1607"},"modified":"2015-06-18T10:14:30","modified_gmt":"2015-06-18T07:14:30","slug":"tymu-pavojus-nepamirskite-pasiskiepyti","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/2015\/06\/18\/tymu-pavojus-nepamirskite-pasiskiepyti\/","title":{"rendered":"Tym\u0173 pavojus \u2013 nepamir\u0161kite pasiskiepyti"},"content":{"rendered":"<p style=\"text-align: justify;\">\n\t&Scaron;iais metais Lietuvoje registruota 14 laboratori&scaron;kai patvirtint\u0173 tym\u0173 atvej\u0173, 6 i&scaron; j\u0173 per paskutines dvi savaites, Kauno apskrityje. Du atvejai kuriems pasirei&scaron;k\u0117 tipiniai tym\u0173 simptomai dar laukia laboratorini\u0173 tyrim\u0173 rezultat\u0173. Sirgo vyresni nei 21 met\u0173 am\u017eiaus asmenys, kuri\u0173 daugum\u0105 buvo neskiepyti arba skiepyti tik viena vakcinos doze.<br \/>\n\tEuropos lig\u0173 prevencijos ir kontrol\u0117s centro duomenimis, nuo 2014 met\u0173 baland\u017eio iki 2015 met\u0173 kovo m\u0117nesio Europoje registruoti 3 809 tym\u0173 atvejai. Visose Europos &scaron;alyse registruojami pavieniai tym\u0173 atvejai arba protr\u016bkiai, daugiausia ligos atvej\u0173 registruota Italijoje bei Vokietijoje. I&scaron; vis\u0173 susirgusi\u0173j\u0173 tymais daugiau nei 80 proc. buvo neskiepyti ir daugiau nei 10 proc. susirgusi\u0173j\u0173 skiepyti nuo tym\u0173 tik kart\u0105.<br \/>\n\tTymai &#8211; viena lengviausiai plintan\u010di\u0173 (u\u017ekre\u010diam\u0173j\u0173) lig\u0173. S\u0105lytis tarp \u017emoni\u0173, trunkantis ilgiau nei 15 min. yra pakankamas, kad asmuo u\u017esikr\u0117st\u0173. Tymais u\u017esikr\u0117t\u0119s asmuo gali u\u017ekr\u0117sti iki 18 imli\u0173 \u017emoni\u0173. Inkubacinis ligos periodas svyruoja nuo 10 iki 21 dienos. U\u017esikr\u0117t\u0119s asmuo kit\u0105 asmen\u012f gali u\u017ekr\u0117sti 4 dienas iki pirm\u0173j\u0173 ligos po\u017eymi\u0173 ir 4 dienas po j\u0173 atsiradimo.\n<\/p>\n<p style=\"text-align: justify;\">\n\t<strong>Tymais u\u017esikre\u010diama:<\/strong><br \/>\n\t&bull; Aerogeniniu (aerozoliniu ir oro la&scaron;eliniu) keliu.<br \/>\n\t&bull; Per kv\u0117pavimo tak\u0173 sekretais suter&scaron;tas rankas ir aplinkos daiktus.\n<\/p>\n<p style=\"text-align: justify;\">\n\t<strong>Pirmieji tym\u0173 po\u017eymiai: <\/strong>kar&scaron;\u010diavimas, sloga, kosulys, aki\u0173 jungin\u0117s u\u017edegimas, Kopliko d\u0117mel\u0117s, makulopapulinis b\u0117rimas (prasideda veido srityje, po to i&scaron;plinta po vis\u0105 k\u016bn\u0105).\n<\/p>\n<p style=\"text-align: justify;\">\n\t<strong>Kaip elgtis susirgus ar \u012ftarus, kad susirgote tymais:<\/strong><br \/>\n\t&bull; kuo skubiau kreiptis \u012f asmens sveikatos prie\u017ei\u016bros \u012fstaig\u0105;<br \/>\n\t&bull; suteikti informacij\u0105 gydytojui apie buvusias keliones pra\u0117jusi\u0173 dviej\u0173 &#8211; trij\u0173 savai\u010di\u0173 laikotarpyje;<br \/>\n\t&bull; vengti kontakto su kitais \u017emon\u0117mis.\n<\/p>\n<p style=\"text-align: justify;\">\n\t<strong>Tymai pavojingi, nes gali sukelti komplikacijas<\/strong>: pneumonij\u0105, vidurin\u0117s ausies u\u017edegim\u0105, viduriavim\u0105, encefalit\u0105, mirt\u012f.\n<\/p>\n<p style=\"text-align: justify;\">\n\t<strong>Vienintel\u0117 apsaugos priemon\u0117:<\/strong> SKIEPAI, tod\u0117l, jei asmuo ne\u017eino savo skiepijimo b\u016bkl\u0117s arba skiepytas tik kart\u0105, rekomenduojama kreiptis \u012f savo &scaron;eimos gydytoj\u0105 ir pasiskiepyti.\n<\/p>\n<p style=\"text-align: justify;\">\n\t<strong>Svarbu paskiepyti vaikus dvejomis tym\u0173, epideminio parotito, raudonuk\u0117s&nbsp; vakcinos doz\u0117mis<\/strong>. Tyrimais \u012frodyta, kad ilgalaikis imunitetas susidaro po dviej\u0173 \u012fskiepyt\u0173 vakcinos dozi\u0173.<br \/>\n\t&nbsp;<br \/>\n\tDaugiau apie tymus skaitykite \u010dia:<br \/>\n\thttp:\/\/www.ulac.lt\/lt\/tymai<br \/>\n\thttp:\/\/www.ulac.lt\/uploads\/downloads\/leidiniai\/tymu_m_06_07.pdf<br \/>\n\thttp:\/\/ecdc.europa.eu\/en\/healthtopics\/measles\/Pages\/index.aspx<br \/>\n\thttp:\/\/www.who.int\/topics\/measles\/en\/\n<\/p>\n<p style=\"text-align: right;\">\n\tInformacijos &scaron;altinis:\n<\/p>\n<p style=\"text-align: right;\">\n\t<a href=\"http:\/\/www.ulac.lt\">www.ulac.lt<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&Scaron;iais metais Lietuvoje registruota 14 laboratori&scaron;kai patvirtint\u0173 tym\u0173 atvej\u0173, 6 i&scaron; j\u0173 per paskutines dvi savaites, Kauno apskrityje. Du atvejai kuriems pasirei&scaron;k\u0117 tipiniai tym\u0173 simptomai dar laukia laboratorini\u0173 tyrim\u0173 rezultat\u0173. Sirgo vyresni nei 21 met\u0173 am\u017eiaus asmenys, kuri\u0173 daugum\u0105 buvo neskiepyti arba skiepyti tik viena vakcinos doze. Europos lig\u0173 prevencijos ir kontrol\u0117s centro duomenimis, nuo&hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[],"tags":[],"class_list":["post-1607","post","type-post","status-publish","format-standard","hentry","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-pV","jetpack_featured_media_url":"","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/1607","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/comments?post=1607"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/1607\/revisions"}],"predecessor-version":[{"id":1608,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/posts\/1607\/revisions\/1608"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/media?parent=1607"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/categories?post=1607"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/lt_lt\/wp-json\/wp\/v2\/tags?post=1607"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}